Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04363801
Title A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer (DisTinGuish)
Acronym DisTinGuish
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA | DEU

No variant requirements are available.